SEC Comment Letter for Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO) — Oct 2, 2024
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: Oct. 2, 2024 · CIK: 0001429260 · Accession: 0000000000-24-011139
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282384
Letter
October 2, 2024 Lindsay A. Rosenwald Chief Executive Officer Fortress Biotech, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands, FL 33154 Re:Fortress Biotech, Inc. Registration Statement on Form S-1 Filed September 27, 2024 File No. 333-282384 Dear Lindsay A. Rosenwald: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Rakesh Gopalan
Show Raw Text
October 2, 2024
Lindsay A. Rosenwald
Chief Executive Officer
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, FL 33154
Re:Fortress Biotech, Inc.
Registration Statement on Form S-1
Filed September 27, 2024
File No. 333-282384
Dear Lindsay A. Rosenwald:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Rakesh Gopalan